Public Sector Pension Investment Board Purchases 1,927 Shares of Humana Inc. (NYSE:HUM)

Public Sector Pension Investment Board grew its position in shares of Humana Inc. (NYSE:HUM) by 71.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,622 shares of the insurance provider’s stock after buying an additional 1,927 shares during the quarter. Public Sector Pension Investment Board’s holdings in Humana were worth $1,727,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of HUM. CarsonAllaria Wealth Management Ltd. lifted its position in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares in the last quarter. Hantz Financial Services Inc. bought a new stake in shares of Humana in the 2nd quarter worth approximately $35,000. Family Firm Inc. bought a new stake in shares of Humana in the 2nd quarter worth approximately $37,000. Hollencrest Capital Management bought a new stake in shares of Humana in the 2nd quarter worth approximately $40,000. Finally, Riverview Trust Co bought a new stake in shares of Humana in the 2nd quarter worth approximately $44,000. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on HUM shares. Piper Sandler started coverage on shares of Humana in a report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price target on the stock. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a report on Friday, August 2nd. TD Cowen boosted their target price on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a report on Wednesday, July 24th. Oppenheimer boosted their target price on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Finally, Truist Financial boosted their price target on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research report on Monday, July 15th. Thirteen analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $398.70.

Humana Price Performance

HUM stock opened at $316.60 on Tuesday. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The company has a market cap of $38.15 billion, a P/E ratio of 19.71, a PEG ratio of 2.44 and a beta of 0.50. The firm has a 50-day moving average of $348.57 and a 200 day moving average of $344.23. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same period in the prior year, the firm earned $8.94 earnings per share. Humana’s revenue was up 10.4% on a year-over-year basis. On average, sell-side analysts forecast that Humana Inc. will post 16.01 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.